title: PARP Inhibitors in Ovarian Cancer Treatment.
authors.affiliation: From the Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York (D.R.S.).
authors.forename: David R
authors.initials: DR
authors.lastname: Spriggs
authors.affiliation: From the Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York (D.R.S.).
authors.forename: Dan L
authors.initials: DL
authors.lastname: Longo
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D000067856:Poly(ADP-ribose) Polymerase Inhibitors